Dorzagliatin as a Glucose Sensitizer Achieved Sustained Glycemic Control in Combination with Metformin in Chinese T2DM Patients in a 52-Week Phase 3 Clinical Trial (DAWN Study)
Copyright ? 2026 Hua Medicine (Shanghai) Ltd. 沪网药械信备字【2026】000123号 沪ICP备14036654号-1沪公网安备 31011502013809号Privacy StatementTerms of Use
Search
How we use cookies
Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our privacy statement.